| Literature DB >> 35821700 |
Yong-Suk Lee1, Sang-Uk Lee1, Tae Min Hong1, Sun Young Joo1.
Abstract
Background: Although it is generally agreed that vitamin D is important for bone health, the role of vitamin D in preventing fractures in children and adolescents remains unclear. Therefore, this study aimed to investigate the prevalence of vitamin D deficiency and insufficiency in healthy Korean children with fractures. Our secondary aim was to compare serum vitamin D levels before and during the coronavirus disease 2019 (COVID-19) outbreak.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35821700 PMCID: PMC9226975 DOI: 10.1155/2022/4410032
Source DB: PubMed Journal: Int J Clin Pract ISSN: 1368-5031 Impact factor: 3.149
Patient demographics.
| Group I ( | Group II ( | Group III ( |
|
| |
|---|---|---|---|---|---|
| Age (years) | 8.2 ± 3.7 | 8.5 ± 3.7 | 8.6 ± 3.5 | 0.409 | 0.357 |
| M : F | 229 (68.6%):105 (31.4%) | 118 (56.2%):92 (43.8%) | 54 (55.7%):43 (44.3%) | 0.003 | 0.019 |
| BMI (kg/m2) | 18.8 ± 4.3 | 18.0 ± 3.1 | 19.2 ± 3.9 | 0.147 | 0.574 |
| Season | <0.001# | 0.045# | |||
| Spring | 62 (18.6%) | 54 (25.7%) | 31 (32.0%) | ||
| Summer | 118 (35.3%) | 64 (30.5%) | 29 (29.9%) | ||
| Autumn | 95 (28.4%) | 32 (15.2%) | 22 (22.7%) | ||
| Winter | 59 (17.7%) | 60 (28.6%) | 15 (15.5%) | ||
| 25(OH)D (ng/mL) | 20.0 ± 7.3 | 23.2 ± 6.9 | 18.8 ± 7.3 | <0.001 | 0.056 |
Data are presented as the mean ± standard deviation or n (%). BMI, body mass index. p value: compared group I with group II, †p value: compared group I with group III, and p value: calculated by the chi-square test.
Details of the fractures.
| Location | Group I | Group III | ||||
|---|---|---|---|---|---|---|
| N (%) | Age (years) | 25(OH)D | N (%) | Age (years) | 25(OH)D | |
| (ng/ml) | (ng/ml) | |||||
| Upper extremity | 237 (71.0%) | 69 (71.1%) | ||||
| Humerus shaft | 9 (2.7%) | 10.9 ± 2.7 | 18.3 ± 4.7 | 4 (4.1%) | 11.8 ± 3.9 | 16.4 ± 3.5 |
| Supracondyle | 79 (23.7%) | 6.3 ± 2.6 | 20.8 ± 8.0 | 23 (23.7%) | 6.4 ± 1.8 | 18.7 ± 6.4 |
| Lateral condyle | 53 (15.9%) | 5.0 ± 1.9 | 21.4 ± 6.8 | 15 (15.5%) | 5.4 ± 1.6 | 19.0 ± 6.1 |
| Medial epicondyle | 16 (4.8%) | 9.3 ± 2.7 | 16.5 ± 5.9 | 5 (5.2%) | 10.4 ± 4.2 | 16.8 ± 2.2 |
| Forearm | ||||||
| Proximal | 31 (9.3%) | 7.3 ± 3.1 | 21.2 ± 7.0 | 9 (9.3%) | 8.3 ± 1.7 | 20.3 ± 4.1 |
| Shaft | 25 (7.5%) | 8.8 ± 3.2 | 21.0 ± 7.8 | 2 (2.1%) | 10.0 ± 1.4 | 18.7 ± 3.8 |
| Distal | 24 (7.2%) | 9.2 ± 3.7 | 21.8 ± 7.0 | 11 (11.3%) | 10.1 ± 3.3 | 19.4 ± 9.4 |
| Lower extremity | 53 (15.9%) | 20 (20.6%) | ||||
| Femur | 13 (3.9%) | 8.9 ± 3.9 | 18.4 ± 8.7 | 4 (4.1%) | 6.5 ± 4.8 | 17.7 ± 0.6 |
| knee | 7 (2.1%) | 11.4 ± 3.4 | 16.6 ± 6.3 | 2 (2.1%) | 12.0 ± 1.4 | 10.8 ± 4.8 |
| Tibia | 4 (1.2%) | 9.3 ± 4.8 | 23.1 ± 4.5 | 4 (4.1%) | 13.0 ± 2.0 | 15.6 ± 5.5 |
| Ankle | 29 (8.7%) | 11.6 ± 3.1 | 15.3 ± 7.0 | 10 (10.3%) | 11.6 ± 1.4 | 17.4 ± 5.1 |
| Hand and foot | 44 (13.2%) | 11.5 ± 3.0 | 21.1 ± 4.4 | 8 (8.2%) | 10.6 ± 4.5 | 20.6 ± 11.3 |
| Total | 334 (100%) | 8.2 ± 3.7 | 20.0 ± 7.3 | 97 (100%) | 8.6 ± 3.5 | 18.5 ± 6.5 |
Data are presented as the mean ± standard deviation, or n (%).
Prevalence of vitamin D deficiency of the patients.
| Variable | Group I ( | Group II ( | Group III ( |
|
|
|---|---|---|---|---|---|
| Serum 25(OH)D | <0.001# | 0.075# | |||
| Deficient | 177 (53.0%) | 69 (32.9%) | 64 (66.0%) | ||
| Insufficient | 140 (41.9%) | 118 (56.2%) | 29 (29.9%) | ||
| Sufficient | 17 (5.1%) | 23 (11.0%) | 4 (4.1%) |
Data are presented as n (%). Deficient: serum 25(OH)D level <20 ng/mL, insufficient: serum 25(OH)D level from 20 to 32 ng/mL, and sufficient: serum 25(OH)D level ≥32 ng/mL. p value: compared group I with group II, †p value: compared group I with group III, and p value: calculated by the chi-square test.
The serum 25(OH)D level of the patients according to season.
| Group I ( | Group II ( |
| Group III ( |
| |
|---|---|---|---|---|---|
|
| 0.392# | 0.150# | |||
| Deficient | 41 (66.1%) | 31 (57.4%) | 26 (83.9%) | ||
| Insufficient | 18 (29.0%) | 17 (31.5%) | 5 (16.1%) | ||
| Sufficient | 3 (4.8%) | 6 (11.1%) | 0 (0%) | ||
| Serum vit D | 18.8 ± 7.7 | 21.3 ± 7.4 | 0.049 | 16.8 ± 4.1 | 0.161 |
|
| <0.001# | 0.915# | |||
| Deficient | 49 (41.5%) | 9 (14.1%) | 13 (44.8%) | ||
| Insufficient | 62 (52.5%) | 46 (71.9%) | 14 (48.3%) | ||
| Sufficient | 7 (5.9%) | 9 (14.1%) | 2 (6.9%) | ||
| Serum vit D | 22.1 ± 6.6 | 25.5 ± 5.7 | 0.001 | 21.1 ± 7.3 | 0.474 |
|
| <0.001# | 0.755# | |||
| Deficient | 46 (48.4%) | 4 (12.5%) | 11 (50.0%) | ||
| Insufficient | 44 (46.3%) | 25 (78.1%) | 9 (40.9%) | ||
| Sufficient | 5 (5.3%) | 3 (9.4%) | 2 (9.1%) | ||
| Serum vit D | 20.2 ± 6.7 | 24.6 ± 6.4 | 0.001 | 19.7 ± 7.6 | 0.774 |
|
| 0.009# | 0.165# | |||
| Deficient | 41 (69.5%) | 25 (41.7%) | 14 (93.3%) | ||
| Insufficient | 16 (27.1%) | 30 (50.0%) | 1 (6.7%) | ||
| Sufficient | 2 (3.4%) | 5 (8.3%) | 0 (0%) | ||
| Serum vit D | 17.5 ± 8.0 | 21.7 ± 7.2 | 0.001 | 15.1 ± 5.0 | 0.287 |
Data are presented as mean ± standard deviation, or n (%). Deficient: serum 25(OH)D level <20 ng/mL, insufficient: serum 25(OH)D level from 20 to 32 ng/mL, and sufficient: serum 25(OH)D level ≥32 ng/mL. p value: compared group I with group II, †p value: compared group I with group III, and p value: calculated by the chi-square test.
Serum 25(OH)D levels according to age group, sex, and BMI.
| Group I ( | Group II ( | Group III ( |
|
| |
|---|---|---|---|---|---|
| Age (years) | |||||
| <10 | 21.4 ± 7.2 | 24.7 ± 7.1 | 19.2 ± 6.8 | <0.001 | 0.037 |
| ≥10 | 17.6 ± 7.0 | 20.2 ± 5.5 | 17.2 ± 5.8 | 0.008 | 0.766 |
| Sex | |||||
| Boys | 20.2 ± 7.5 | 23.6 ± 6.7 | 18.2 ± 6.6 | <0.001 | 0.071 |
| Girls | 19.5 ± 7.0 | 22.7 ± 7.2 | 18.8 ± 6.5 | 0.002 | 0.605 |
| BMI (kg/m2) | |||||
| Normal | 21.2 ± 7.4 | 23.4 ± 6.9 | 19.4 ± 7.5 | 0.011 | 0.174 |
| Overweight | 18.3 ± 7.0 | 22.2 ± 6.3 | 16.7 ± 5.7 | <0.001 | 0.232 |
Data are presented as mean ± standard deviation or n (%). BMI, body mass index. p value: compared group I with group II and †p value: compared group I with group III.